N/A

Crea, F., Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy, <<EUROPEAN HEART JOURNAL>>, 2021; 42 (31): 2973-2985. [doi:10.1093/eurheartj/ehab277] [http://hdl.handle.net/10807/204471]

Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy

Crea, Filippo
2021

Abstract

N/A
2021
Inglese
Crea, F., Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy, <<EUROPEAN HEART JOURNAL>>, 2021; 42 (31): 2973-2985. [doi:10.1093/eurheartj/ehab277] [http://hdl.handle.net/10807/204471]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/204471
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 11
social impact